Story thread · 3 reports / 3 sources

Lundbeck Is Said to Express Interest in Buying Xeris Biopharma

bloomberg.com · 3h · first report

H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.

The coverage

  1. Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports

    investing.com · 21m

  2. Xeris Biopharma jumps on report of interest from H Lundbeck

    seekingalpha.com · 3h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.